[서울=뉴스핌] Reporter Seo Young-wook = Experts said that all of the corona 19 vaccines planned to be introduced in Korea “are reported to have lower defense capabilities against the South African mutant virus.” However, the vaccine was recommended to be vaccinated, saying that it is more’benefit’ as it can prevent the symptoms from worsening to severe.
In addition, the government still failed to give a clear answer regarding the effectiveness of the AstraZeneca Corona 19 vaccine against the elderly over 65 years old. The Ministry of Food and Drug Safety is planning to hold a third advisory meeting for AstraZeneca vaccine this week and decide whether to approve the product.
On the afternoon of the 8th, the Korea Centers for Disease Control and Prevention (KCDC) held a public briefing on the Corona 19 vaccine and made this announcement.
 |
| [서울=뉴스핌] Reporter Paik Baek-hyuk = Army field support team is warming hands on the stove at the temporary screening clinic for novel coronavirus infection (Corona 19) in the Seoul City Hall plaza in Jung-gu, Seoul. 2020.12.30 [email protected] |
Nam Jae-hwan, a professor at the Catholic University’s Department of Medical Life Science, who attended the briefing, said, “The people are aware that there are a lot of worries about the mutant virus.” “You don’t have to worry about it.”
However, “It is reported that the defense ability against the South African mutant virus is lowered,” he said. “One of the functions of the vaccine is to prevent the body from getting sick when the virus enters my body. You don’t have to worry.”
Choi Won-seok, a professor of infectious medicine at Korea University Ansan Hospital, reassured, “It is true that the development period of the corona vaccine was relatively short, but that did not mean that the intermediate process was omitted.”
“There are still things I don’t know, but it is much more beneficial to get vaccination by personal judgment. If you are a high-risk group, it is much more beneficial.” Do” he advised.
He explained that the effect of the AstraZeneca vaccine for the elderly is a part to be considered.
Prof. Won-Seok Choi explained, “First of all, it is the difference in how experts interpret AstraZeneca vaccine, rather than looking at other data.” .
The problem is the effect. Experts say that when all ages over 18 years old are analyzed at once, valid results come out, whereas when only over 65 years old is analyzed separately, the number of senior citizens is small, so it is impossible to judge statistical significance.
Professor Choi said, “It is true that statistical significance has not been confirmed for the elderly over the age of 65. If the number of cases collected in the future increases and the results of subsequent clinical studies come out, statistical significance data can be secured. “It is a part for experts to worry about.”
“The Ministry of Food and Drug Safety will hold a third advisory meeting this week to determine the final advisory result for the AstraZeneca vaccine,” said Eun-kyung Jung, head of the COVID-19 vaccination and response promotion team. It is not that there is not, but because there is not enough data to judge, it is a recommendation that you need to be careful about vaccination.
According to these results, the vaccination plan will also be adjusted, explained Eun-kyung Jung.
The government said it is continuing to review plans for additional vaccines. “Currently, we have a vaccine for 56 million people, and we are continuing to review additional supply through NovaVax,” said General Manager Eun-kyung Jung.